Skip to main content
Clinical Trials/CTRI/2024/06/068935
CTRI/2024/06/068935Not yet recruitingPhase 3

Comparative study for efficacy of L-carnitine and N-acetyl cysteine on iron overload induced oxidative stress in patients with thalassemia: A Randomized Control Trial - NI

Dr Pragna Roy0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1)Patients with thalassemia on blood transfusion
  • 2)Patients or legally authorized representative willing to give informed consent and assent for the trial.

Exclusion Criteria

  • 1)Patients with history of allergic reactions attributed to compounds of similar chemical or biologic composition of N-Acetyl-Cysteine and L-Carnitine
  • 2)Patients with history of central nervous system diseases (like epilepsy, psychiatric disorder) or taking any medicine for such illness.
  • 3)Patients with history of severe renal or hepatic disease (like hepatitis B or C)
  • 4)Patients with history of bronchospastic diseases (like asthma)
  • 5)Patients with history of hypothyroid disorder
  • 6)Patients on warfarin or acenocoumarin therapy

Investigators

Sponsor
Dr Pragna Roy

Similar Trials